BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$327.89 USD
+1.29 (0.39%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $327.95 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/24/2024
Time: -- |
9/2024 | $2.13 | 0.00% |
Earnings Summary
For their last quarter, BioRad Laboratories (BIO) reported earnings of $3.11 per share, beating the Zacks Consensus Estimate of $2.12 per share. This reflects a positive earnings surprise of 46.70%. Look out for BIO's next earnings release expected on October 24, 2024. For the next earning release, we expect the company to report earnings of $2.13 per share, reflecting a year-over-year decrease of 8.58%.
Earnings History
Price & Consensus
Zacks News for BIO
National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services